ArticleThe pharmacogenomics journal2019

Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort.

Ricardo Pinto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.